Jefferies Downgrades Humana to Hold, Lowers Price Target to $253
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst David Windley has downgraded Humana from Buy to Hold and significantly lowered the price target from $419 to $253.
October 07, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jefferies has downgraded Humana from Buy to Hold, with a significant reduction in the price target from $419 to $253, indicating a less optimistic outlook.
The downgrade from Buy to Hold by Jefferies, along with a substantial reduction in the price target, suggests a negative short-term outlook for Humana's stock. This could lead to a decrease in investor confidence and a potential drop in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100